Avacta Group (LON: AVCT) shares are largely unchanged - up 2% - on a declaration from the company that no fundraise is imminent. The real information content here is that no one - well, OK, very few - thought that a fundraise was imminent.
That there could be a fundraise, well Avacta is a research pharma company. Until there's actually something authorised which can be sold there's no real possibility of debt financing - there's no asset to secure such borrowings. So, everything has to be paid for from shareholder capital. The development path, the lifecycle, of such pharma companies is achieve a research goal, raise funds to attempt to reach the next one So, this idea that there might be a fundraise is not out of the ordinary. It is part of how we expect the company to develop over time.
On the other hand we get this statement: “Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, notes the recent market speculation regarding a possible fundraising.” That probably means a couple of newspaper columns speculating that a fundraise might be about to happen. The response is: “While this includes maintaining a dialogue with both current shareholders and other potential investors, no fundraising is imminent.”
Now that's a strong statement in an official release. Barring something truly exceptional happening that really does mean that Avacta cannot launch a fundraise in this near future. Because they've announced, in an official release to the exchange, that they're not going to do so. Sure, the definition of “imminent” can be argued but it is at least weeks if not months.

Avacta Group share price from London Stock Exchange
Fundraises generally crash the share price of a company. For the obvious joint reasons that a) it means more shares around so each one is worth less and b) they're generally launched at a discount. So, a declaration that a fundraise is not going to be launched - if people thought one was going to be - should generally be positive for a share price.
But here's we've a pretty much “Meh” response to the idea of there being no fundraise. What this tells us is that few people actually believed there would be. The absence of an Avacta fundraise is not a price mover, therefore few believed there would be one. Possibly only the couple of people who wrote articles thinking there might be one.
This would not be the first time that the financial press has got things not quite right after all.